Monday, October 20, 2008: 7:30 AM
Columbus A-C (Hyatt Regency Penns Landing)
Poster Number Acronyms
USE OF THE NET BENEFIT APPROACH IN PRIORITIZING ANTIHYPERTENSIVE MEDICATIONS
Torbjørn Wisløff, M.Sc., Norwegian Knowledge Centre for Health Services, Oslo, Norway, Randi Selmer, PhD, The Norwegian Institute of Public Health, N-0403 Oslo, Norway, Sigrun Halvorsen, PhD, Ullevål University Hospital, Oslo, Norway and Ivar Sønbø Kristiansen, MD, PhD, MPH, Institute of Health Economics, N-0317 Oslo, Denmark Norway
COST-EFFECTIVENESS OF PHARMACOGENETIC-BASED DOSING OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
Mark Eckman, MD, MS1, Jonathan Rosand, MD, MSc2, Steven M. Greenberg, MD, PhD2 and Brian Gage, MD, MSc3, (1)University of Cincinnati, Cincinnati, OH, (2)Massachusetts General Hospital, Boston, MA, (3)Washington University, St Louis, MO
VALUE OF INFORMATION ANALYSIS ON ERYTHROPOIESIS-STIMULATING AGENTS IN ANEMIC HEART FAILURE - GAUGING THE VALUE OF FUTURE RESEARCH DIRECTIONS
Benjamin P. Geisler, MD1, Uwe Siebert, MD, MPH, MSc, Sc2, Irfan Khan3, G. Scott Gazelle, MD, MPH, PhD1, David J. Cohen, MD, MSc4 and Alexander Goehler, MD, MSc, MPH1, (1)Massachusetts General Hospital, Boston, MA, (2)University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, (3)Amgen, Inc., Thousand Oakes, CA, (4)Mid America Heart Insitute, St. Luke's Hospital, Kansas City, MO
ERYTHROPOIESIS STIMULATING AGENTS IN THE TREATMENT OF ANEMIC HEART FAILURE PATIENTS – A COST-UTILITY ANALYSIS
Alexander Goehler, MD, MSc, MPH, Massachusettes General Hospital, Boston, MA, Benjamin P. Geisler, MD, Harvard Medical School, Boston, MA, Irfan Khan, Amgen, Inc., Thousand Oakes, CA, Uwe Siebert, MD, MPH, MSc, Sc, University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria and David J. Cohen, MD, MSc, Mid America Heart Insitute, St. Luke's Hospital, Kansas City, MO
COST-EFFECTIVENESS OF CIRCULATING BIOMARKERS IN MANAGING STABLE CORONARY DISEASE
Martin Henriksson, Phd1, Stephen Palmer, MSc2, Mark Sculpher, PhD2, Keith Abrams, PhD3 and Harry Hemmingway, FRCP4, (1)Center for medical technology assessment, Linköping, Sweden, (2)University of York, York, United Kingdom, (3)University of Leicester, Leicester, United Kingdom, (4)University College London Medical School, London, United Kingdom
WHAT IS THE MOST EFFECTIVE STRATEGY FOR DISTRIBUTING CANCER SCREENING DECISION AIDS IN PRIMARY CARE?
Charles Brackett, MD, MPH1, Nan Cochran, MD2, Martha Coutermarsh1, Catharine F. Clay, MA, BSN1, Ephrem J. Micaiah, MPH3, Stephen Kearing, MS3 and Blair Brooks, MD1, (1)Dartmouth-Hitchcock Medical Center, Lebanon, NH, (2)White River Junction VA Medical Center, White River Junction, VT, (3)Dartmouth Medical School, Hanover, NH
DO DECISION AIDS ENCOURAGE SHARED DECISION-MAKING? A THEORY-DRIVEN EVALUATION WITH ETHNICALLY DIVERSE PATIENTS
Dominick Frosch, PhD1, France Légaré, MD, PhD2 and Carol Mangione, MD, MSPH1, (1)UCLA, Los Angeles, CA, (2)CHUQ Research Center-Hôpital St-François d'Assise, Quebec, QC, Canada
PATIENT DECISION AID FOR TOTAL KNEE ARTHROPLASTY: RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECT ON WAIT TIMES AND DECISION QUALITY
Dawn Stacey, RN, PhD1, Gillian Hawker, MD, MSc2, Annette M. O'Connor, RN, PhD1, Geoffrey Dervin, MD1, Monica Taljaard, PhD1, Peter Tugwell, MD1, Ivan Tomek, MD3, Marie-Pascale Pomey, MD, PhD4 and Dean Fergusson, MHA, PhD1, (1)University of Ottawa; Ottawa Health Research Institute, Ottawa, ON, Canada, (2)University of Toronto, Toronto, ON, Canada, (3)Dartmouth Hitchcock Medical Center, Lebanon, NH, (4)Université de Montréal, Montreal, QC, Canada
DISTRESS AND DECISIONAL REGRET AFTER THE SURGICAL DECISION FOR EARLY STAGE BREAST CANCER
Stephen Kearing, MS1, E. Dale Collins, MD2, Catharine F. Clay, MA, BSN2, Annette M. O'Connor, PhD3 and Alyssa Cretarola, BS2, (1)Dartmouth Medical School, Hanover, NH, (2)Dartmouth Hitchcock Medical Center, Lebanon, NH, (3)University of Ottawa, Ottawa, ON, Canada
USE OF A DECISION AID FOR PATIENTS WITH TYPE 2 DIABETES INTENSIFYING TREATMENT. A RANDOMIZED CLUSTERED TRIAL
Victor M. Montori, MD, MSc, Rebecca J. Mullan, MSc, Maggie Breslin, MA, Carolyn M. Valone Bell, MS, MA, Sandra Bryant, MS, Teresa J.H. Christianson, Steven A. Smith, MD and Nilay D. Shah, PhD, Mayo Clinic, Rochester, MN
A SURVEY OF PHYSICIAN ATTITUDES TOWARD COMPUTER-BASED DIAGNOSTIC SUPPORT SYSTEMS
C. Adam Probst, BA, Wichita State University, Wichita, KS, Victoria A. Shaffer, PhD, Department of Psychology, Wichita, USA USA and Raymond Chan, M.D., Children's Mercy Hospital, Kansas City, MO
FEASIBILITY OF IN-CLINIC VIEWING OF PATIENT DECISION AID VIDEOS
Kylee M. Miller, BA1, Jennifer M. Griffith, DrPH, MPH1, Carmen Lewis, MD, MPH1, Robb Malone, PharmD1 and Michael Pignone, MD, MPH2, (1)University of North Carolina at Chapel Hill, Chapel Hill, NC, (2)University of North Carolina at Chapel Hill, Chapel Hill, USA
DECISION SUPPORT FOR THE DEVELOPING WORLD: A PORTABLE HEALTH POLICY MODEL FOR PNEUMOCOCCAL CONJUGATE VACCINATION
C. Greg Hagerty, PhD1, Frank A. Sonnenberg, MD1, Maria Knoll, PhD2, Orin Levine, PhD2 and Anushua Sinha, MD, MPH3, (1)University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, New Brunswick, NJ, (2)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (3)University of Medicine and Dentistry of New Jersey - New Jersey Medical School, Newark, NJ
BUDGET AND HEALTH IMPACT OF STRATEGIES FOR PREVENTING PRESSURE ULCERS IN LONG-TERM CARE FACILITIES IN ONTARIO
Márcio Machado, PhD, Ba Pham, MSc, Wendong Chen, MD, Anita Stern, PhD and Murray Krahn, MD, MSc, University of Toronto, Toronto, ON, Canada
THE COST OF QUALITY-OF-CARE IMPROVEMENTS FOR DIABETES
Julia E. Aledort, PhD, T. Nuckols, MD, J. Lai, MH Go, A. Griffin, J. Keesey, L. Hiatt, J. Adams, PhD and E. McGlynn, PhD, RAND Corporation, Santa Monica, CA
COST COMPARISON BETWEEN PAPER-AND-PENCIL AND WEB BASED DATA COLLECTION FOR LARGE-SCALE LONGITUDINAL HEALTH OUTCOMES RESEARCH
Jeanette M. Broering, RN, MS, MPH1, Luke Tso, PharmD2, Suzanne C. Lessard, BA1, Ali Zargham, BA1 and Leslie Wilson, PhD, MS, BS2, (1)University of California San Francisco, San Francisco, CA, (2)University of California, San Francisco, San Francisco, CA
DEVELOPMENT OF AN ITEM RESPONSE THEORY-DERIVED ADAPTIVE SHORT FORM FOR OUTCOME ASSESSMENT
Christine M. McDonough, Ph.D., P.T.1, Wendy J. Coster, Ph.D., O.T.R.2, Pengsheng Ni, M.D., M.P.H.1, Stephen M. Haley, Ph.D., P.T.1 and Alan M. Jette, Ph.D., P.T.1, (1)Boston University School of Public Health, Boston, MA, (2)Boston University, Boston, MA
COMPARISON OF VALUATIONS BY PATIENTS, HEALTH CARE PROFESSIONALS, AND LAYPERSONS USING MULTIPLE-OUTCOME HEALTH STATE VIGNETTES
Denise Bijlenga, MSc1, Erwin Birnie, PhD2, Ben W.J. Mol, PhD, MD1 and Gouke J. Bonsel, PhD, MD2, (1)Academic Medical Centre, Amsterdam, Netherlands, (2)Erasmus Medical Centre, Rotterdam, Netherlands
RESPONSIVENESS OF FIVE PREFERENCE-BASED MEASURES OF HEALTH-RELATED QUALITY OF LIFE IN CATARACT
Robert M. Kaplan, PhD1, Ron D. Hays, PhD2, David Feeny, PhD3, Mari Palta, PhD4, Theodore G. Ganiats, MD5 and Dennis G. Fryback, PhD4, (1)University of California Los Angeles, Los Angeles, CA, (2)University of California, Los Angeles, Los Angeles, CA, (3)Health Utilities, Inc., and Kaiser Permanente Northwest Center for Health Research, Portland, OR, (4)University of Wisconsin, Madison, WI, (5)UCSD School of Medicine, 9500 Gilman Drive, La Jolla, CA
ARTHROSCOPIC PARTIAL MENISCECTOMY IN INDIVIDUALS WITH SYMPTOMATIC OSTEOARTHRITIS: WHO BENEFITS?
Lisa G. Suter, MD1, Liana Fraenkel, MD, MPH1, A. David Paltiel, PhD1, Jeffrey N. Katz, MD, MS2, Andreas Gomoll2 and Elena Losina, PhD2, (1)Yale School of Medicine, New Haven, CT, (2)Brigham and Women's Hospital, Boston, MA
MODELING SCREENING AND PREVENTION OF ALZHEIMER'S DISEASE
Nicolas M. Furiak, MS1, Kristin Kahle-Wrobleski, PhD2, Eric R. Siemers, MD2, Timothy Klein, BS1, Eric Sarpong, PhD2 and Robert W. Klein, MS1, (1)Medical Decision Modeling Inc., Indianapolis, IN, (2)Eli Lilly & Company, Indianapolis, IN
EFFECT OF APPLYING A TREATMENT THRESHOLD IN A POPULATION. AN EXAMPLE OF PULMONARY TUBERCULOSIS IN RWANDA
Jef Van den Ende, PhD1, Julie Mugabekazi, MD2, Juan Moreira, MD1, Eric Seryange, MD2, Paulin Basinga, MD3, Zeno Bisoffi, Md4, Joris Menten, MA1 and Marleen Boelaert, MPH, PhD1, (1)Institute of Tropical Medicine, Antwerp, Belgium, (2)Centre Hospitalier Universitaire de Kigali, Kigali, Rwanda, (3)Universite Nationale de Rwanda, Kigali, Rwanda, (4)Centro per le Malattie Tropicali – Ospedale Sacro Cuore, Verona, Italy
PSYCHOMETRIC PROPERTIES OF A NEW SUBJECTIVE NUMERACY SCALE: CLASSICAL AND IRT ANALYSES
Christina R. Studts, PhD1, Jamie L. Studts, PhD2 and Michael A. Andrykowski, PhD1, (1)University of Kentucky College of Medicine, Lexington, KY, (2)University of Kentucky College of Medicine, Lexington, KY KY, USA USA
PROSTATE CANCER SCREENING DECISION MAKING: THE DECISIONS SURVEY
Richard M. Hoffman, MD, MPH1, Michael Barry, MD2, Brian J. Zikmund-Fisher, PhD3, Mary F. McNaughton-Collins, MD2, Carrie A. Levin, PhD4 and Mick P. Couper, PhD5, (1)University of New Mexico School of Medicine, Albuquerque, NM, (2)Harvard University, Boston, MA, (3)VA Ann Arbor Healthcare System & University of Michigan, Ann Arbor, MI, (4)Foundation for Informed Medical Decision Making, Boston, MA, (5)University of Michigan, Ann Arbor, MI
PHYSICIANS' LIFE EXPECTANCY ESTIMATES AND COLON CANCER SCREENING RECOMMENDATIONS IN ELDERLY PATIENTS
Carmen Lewis, MD, MPH, Christopher DeLeon, BS, Denise A. Esserman, PhD, Jennifer M. Griffith, DrPH, MPH, Donald Pathman, MD, MPH, Carol Golin, MD and Michael Pignone, MD, MPH, University of North Carolina at Chapel Hill, Chapel Hill, NC
CONDORDANCE OF PATIENT-REPORTED DECISION MAKING PREFERENCES AND PROCESSES USED DURING PHYSICAL EXAMS
Tracy Wunderlich, MA1, Greg Cooper, MD2, George Divine, PhD1, Susan A. Flocke, PhD2, Laura A. Siminoff3, Kurt Stange, MD2 and Jennifer Elston Lafata, PhD1, (1)Henry Ford Health System, Detroit, MI, (2)Case Western Reserve University, Cleveland, OH, (3)Virginia Commonwealth University, Richmond, VA
TRADING LIFE AND HEALTH FOR OTHER GOALS
Alan Schwartz, PhD1, Gordon B. Hazen, PhD2, Ariel Leifer1 and Paul S. Heckerling, MD1, (1)University of Illinois at Chicago, Chicago, IL, (2)Northwestern University, Evanston, IL
NARRATIVES IN ONLINE COMMUNITIES AND WOMEN'S DECISIONS ABOUT BIRTH ATTENDANTS AND BIRTH PLACE
Holly Witteman1, Sarah Whyte2, Laura O'Grady3, Erica Sutton1, Michelle Janutka1, Jacqueline Bender1, Carolynn Prior4, Murray Enkin5, Kirstin Borgerson6 and Nadine Wathen7, (1)University of Toronto, Toronto, ON, Canada, (2)University of Waterloo, Waterloo, ON, Canada, (3)University Health Network, Toronto, ON, Canada, (4)Sages Femmes Rouge Valley Midwives, Scarborough, ON, Canada, (5)McMaster University, Hamilton, ON, Canada, (6)Dalhousie University, Halifax, NS, Canada, (7)University of Western Ontario, London, ON, Canada
COLORECTAL CANCER SCREENING RECOMMENDATIONS IN PRIMARY CARE
Jennifer Elston Lafata, PhD1, Greg Cooper, MD2, George Divine, PhD1, Susan A. Flocke, PhD2, Laura A. Siminoff3, Kurt Stange, MD2 and Tracy Wunderlich, MA1, (1)Henry Ford Health System, Detroit, MI, (2)Case Western Reserve University, Cleveland, OH, (3)Virginia Commonwealth University, Richmond, VA
PATIENT-REPORTED CONTENT OF DIABETES TREATMENT DISCUSSIONS WITH PHYSICIANS AND LEVEL OF GLYCEMIC CONTROL
Jennifer Elston Lafata, PhD1, George Divine, PhD1, Elizabeth Dobie, MPH1, Bruce D. McCarthy, MD, MPH2, Ninee Yang, MA1 and Marianne Ulcickas Yood, DSc, MPH3, (1)Henry Ford Health System, Detroit, MI, (2)Allina Medical Group, Minneapolis, MN, (3)Yale University School of Medicine, New Haven, CT
CANCER CLINICAL TRIALS PARTICIPATION RATES IN FLORIDA
Margaret M. Byrne, PhD1, Julie Kornfeld, MPH2, Stefan Gluck, MD, PHD2, Judith Hurley, MD2 and Michael Antoni2, (1)University of Miami, Miami, USA USA, (2)University of Miami, Miami, FL
PREFERENCES FOR PREVENTION PROGRAMS AGAINST CHRONIC DISEASE: DOES EXPECTED CAUSE OF DEATH MATTER?
Arna S. Desser, PhD, University of Oslo, N-0864 Oslo, Norway, Dorte Gyrd-Hansen, MSc, PhD, University of Southern Denmark, Odense, DK-5000 Odense C, Denmark, Jan Abel Olsen, Univeristy of Tromsø, Tromsø, Norway and Ivar Sønbø Kristiansen, MD, PhD, MPH, Institute of Health Economics, N-0317 Oslo, Denmark Norway
PERCEIVED CARDIOVASCULAR RISK IN OBSERVATION UNIT PATIENTS WITH SYMPTOMS OF POSSIBLE ACS
David Katz, MD, MSc1, Patricia Lounsbury, RN, BC, BSN, MEd2, Mark A. Graber, MD2, Steven Hillis, PhD3 and Alan J. Christensen, PhD2, (1)University of Iowa Carver College of Medicine, Iowa City, IA, (2)University of Iowa, Iowa City, IA, (3)VA Iowa City Health Care System, Iowa City, IA
DETERMINING THE IMPACT OF A NATIONAL PUBLIC HEALTH EDUCATION PROGRAM THAT TEACHES THE IMPORTANCE OF FAMILY HISTORY OF DIABETES: CAN GOOD NEWS DO BAD?
Anjali D. Oza, PhD, (Candidate)1, Thomas Best, MS2, Anirban Basu, PhD3, Elbert S. Huang, MD, MPH1 and David O. Meltzer, MD, PhD1, (1)University of Chicago, Chicago, IL, (2)University of Chicago Medical Center, Chicago, IL, (3)University of Chicago, Chicago, USA
PATIENTS' UNDERSTANDING OF THE TIME HORIZON OF HEALTH RISK
Etienne Mullet, PhD, Institute of Advanced Studies, Université de Toulouse Le Mirail, Toulouse, 31058 Cedex 9, France, Paul Clay Sorum, MD, PhD, Albany Medical College, Latham, NY and Maria Teresa Muñoz Sastre, PhD, Université de Toulouse Le Mirail, Toulouse, France
CORONARY HEART DISEASE RISK PERCEPTIONS AND COMMUNICATION AMONG TYPE 2 DIABETES MELLITUS PATIENTS AND PRIMARY CARE PHYSICIANS
Todd A. Doyle, MS1, Mary de Groot, PhD1, William M.P. Klein, PhD2 and Jay Shubrook, DO3, (1)Ohio University, Athens, OH, (2)University of Pittsburgh, Pittsburgh, PA, (3)Ohio University College of Osteopathic Medicine, Athens, OH
IMPACTS OF NHI HOSPITAL PRESCRIPTION CEILING POLICY ON QUANTITY AND EXPENDITURES FOR DIABETIC MEDICATION IN TAIWAN
Herng-Chia Chiu, PhD, Kaohsiung Medical University, Kaohsiung, Taiwan, Yu-Chin Hsu, MHA, Hong-sen Pharmaceutical Company, Kaohsiung, Taiwan and Shyi-Jang Shin, MD, Chung-Ho Memorial Hospital,Kaohsiung Medical University, Kaohsiung, Taiwan
![[ Visit Client Website ]](images/banner.gif)